Salmon Sean's most recent trade in Medtronic Plc was a trade of 645 Ordinary Shares done at an average price of $82.5 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medtronic | Sean M. Salmon | EVP & President Cardiovascular | 16 Dec 2024 | 645 | 64,722 (0%) | 0% | 82.5 | 53,200 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 02 Aug 2024 | 5,462 | 68,546 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 02 Aug 2024 | 5,462 | 0 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 02 Aug 2024 | 2,779 | 65,110 (0%) | 0% | 81.5 | 226,516 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 02 Aug 2024 | 657 | 67,889 (0%) | 0% | 81.5 | 53,552 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 29 Jul 2024 | 106,260 | 106,260 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 29 Jul 2024 | 35,938 | 35,938 | - | - | Performance Share Unit | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 29 Jul 2024 | 14,375 | 63,084 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 21 Feb 2024 | 16,035 | 48,289 (0%) | 0% | 85.1 | 1,364,899 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 21 Feb 2024 | 16,035 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 21 Feb 2024 | 16,035 | 78,984 (0%) | 0% | 74.8 | 1,200,059 | Ordinary Shares | |
| Medtronic | Salmon Sean | EVP & President Cardiovascular | 21 Feb 2024 | 13,066 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Salmon Sean | EVP & President Cardiovascular | 21 Feb 2024 | 13,066 | 62,949 (0%) | 0% | 62.8 | 820,022 | Ordinary Shares | |
| Medtronic | Salmon Sean | EVP & President Cardiovascular | 21 Feb 2024 | 13,066 | 64,324 (0%) | 0% | 85.2 | 1,112,570 | Ordinary Shares | |
| Medtronic | Salmon Sean | EVP & President Cardiovascular | 21 Feb 2024 | 1,594 | 13,066 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 21 Feb 2024 | 1,594 | 77,390 (0%) | 0% | 85.1 | 135,586 | Ordinary Shares | |
| Medtronic | Salmon Sean | EVP & President Cardiovascular | 21 Feb 2024 | 1,594 | 49,833 (0%) | 0% | 62.8 | 100,039 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 08 Dec 2023 | 435 | 48,103 (0%) | 0% | 79.3 | 34,482 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 03 Aug 2023 | 5,604 | 0 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 03 Aug 2023 | 5,604 | 52,095 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 03 Aug 2023 | 4,369 | 47,726 (0%) | 0% | 84.5 | 369,137 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 31 Jul 2023 | 68,196 | 68,196 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 31 Jul 2023 | 21,214 | 21,214 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 31 Jul 2023 | 9,686 | 46,290 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 13 Dec 2022 | 16,631 | 36,088 (0%) | 0% | 80.5 | 1,338,736 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 13 Dec 2022 | 14,823 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 13 Dec 2022 | 14,823 | 52,719 (0%) | 0% | 55.3 | 820,008 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 13 Dec 2022 | 1,808 | 37,896 (0%) | 0% | 55.3 | 100,019 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 13 Dec 2022 | 1,808 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 07 Dec 2022 | 300 | 36,088 (0%) | 0% | 79.0 | 23,712 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 01 Aug 2022 | 67,924 | 67,924 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 01 Aug 2022 | 21,487 | 21,487 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 01 Aug 2022 | 8,595 | 36,214 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & President Cardiovascular | 29 Jul 2022 | 5,808 | 27,619 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 15 Dec 2021 | 89 | 33,083 (0%) | 0% | 104.9 | 9,340 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 05 Nov 2021 | 245 | 33,172 (0%) | 0% | 123.0 | 30,130 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 21,129 | 33,329 (0%) | 0% | 134.1 | 2,832,976 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 21,129 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 21,129 | 54,458 (0%) | 0% | 38.8 | 820,016 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 7,290 | 33,329 (0%) | 0% | 134.1 | 977,516 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 4,713 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 4,713 | 40,619 (0%) | 0% | 38.2 | 180,037 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 2,577 | 0 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 25 Aug 2021 | 2,577 | 35,906 (0%) | 0% | 38.8 | 100,013 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 02 Aug 2021 | 46,867 | 46,867 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 02 Aug 2021 | 13,714 | 13,714 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 02 Aug 2021 | 5,486 | 33,329 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 02 Aug 2021 | 2,272 | 27,843 (0%) | 0% | 131.3 | 298,336 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | 02 Aug 2021 | 1,085 | 1,085 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 01 Feb 2021 | 16,314 | 16,314 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 01 Feb 2021 | 4,947 | 4,947 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 01 Feb 2021 | 1,979 | 30,007 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 03 Nov 2020 | 220 | 27,900 (0%) | 0% | 103.1 | 22,689 | Ordinary Shares | |
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 09 Oct 2020 | 11,042 | 11,042 | - | - | Performance Share Units | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 03 Aug 2020 | 45,340 | 45,340 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 03 Aug 2020 | 30,227 | 30,227 | - | - | Stock Option (Right to Buy) | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 03 Aug 2020 | 4,932 | 28,041 (0%) | 0% | 0 | Ordinary Shares | ||
| Medtronic | Sean Salmon | EVP & Group President Diabetes | 03 Aug 2020 | 1,575 | 1,575 | - | - | Stock Option (Right to Buy) |